Co-authored by investigators of VHIO’s Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results…
Cancer Genomics Group
Gilead Sciences, in collaboration with the Carlos III Health Institute (ISCIII), held the award ceremony for the 10th Edition of…
Developed by VHIO investigators, VIGex is a gene expression signature that classifies solid tumors into three categories based on the…
Researchers at the Vall d’Hebron Institute of Oncology (VHIO), part of the Vall d’Hebron Campus, have found that breast milk…
In an invited viewpoint article published in the Cancer Discovery, co-authors Elena Garralda, Executive Director of VHIO’s Research Unit for…
Launched by the American Association for Cancer Research (AACR) back in 2015, the AACR Project Genomics Evidence Neoplasia Information Exchange…
Thursday, February 04 2021, not only celebrates World Cancer Day’s 21st birthday but also the final year of its ‘I…
During 2021, the Vall d’Hebron Institute of Oncology will be the first center in Europe to establish a liquid biopsy…
